Laman UtamaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$30.23
Selepas Waktu Dagangan:(0.00%)0.00
$30.23
Tutup: 27 Feb, 5:52:00 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$29.98
Julat hari
$29.01 - $30.52
Julat tahun
$22.24 - $45.99
Permodalan pasaran
1.77B USD
Bilangan Purata
886.93K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 19.97J | 86.09% |
Perbelanjaan pengendalian | 51.61J | -0.17% |
Pendapatan bersih | -108.04J | -11.93% |
Margin untung bersih | -541.09 | 39.85% |
Pendapatan bagi setiap syer | -1.85 | -6.32% |
EBITDA | -120.31J | 2.72% |
Kadar cukai berkesan | 0.93% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 854.42J | -4.40% |
Jumlah aset | 1.30B | -22.00% |
Jumlah liabiliti | 104.11J | -14.83% |
Jumlah ekuiti | 1.19B | — |
Syer tertunggak | 58.59J | — |
Harga kepada buku | 1.47 | — |
Pulangan pada aset | -22.66% | — |
Pulangan pada modal | -23.73% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -108.04J | -11.93% |
Tunai daripada operasi | -96.21J | 27.75% |
Tunai daripada pelaburan | 90.08J | 283.24% |
Tunai daripada pembiayaan | 2.56J | -47.19% |
Perubahan bersih dalam tunai | -3.58J | 97.98% |
Aliran tunai bebas | -62.05J | 42.58% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
540
